[Skip to Content]
[Skip to Content Landing]
Letters
December 22/29, 1999

Safety of FDA-Approved Drugs

Author Affiliations
 

Copyright 1999 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.1999

JAMA. 1999;282(24):2297-2298. doi:10.1001/jama.282.24.2297

To the Editor: Dr Friedman and colleagues1 downplayed serious safety questions about dexfenfluramine, mibefradil, and bromfenac sodium, which were approved in 1996-1997 and subsequently removed from the market, that were raised prior to marketing. Furthermore, Friedman et al failed to acknowledge that these drugs did not represent significant advances over the numerous approved drugs in their therapeutic categories.

×